Navigation Links
Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes

Liraglutide Liraglutide

1.2 mg + 1.8 mg + Placebo +

metformin + metformin + metformin +

rosiglitazone rosiglitazone rosiglitazone

N=178 N=178 N=177

Final HbA1c, %

Change HbA1c from 7.0 7.1 7.9

baseline % points -1.48* -1.48* -0.5

% HbA1c achieving

<7.0% 58* 54* 28

% HbA1c achieving

< or = 6.5% 36* 37* 14

Mean change in weight

from baseline, kg -1.02* -2.02 0.60

Mean change in

FPG from baseline,

mmol/L -2.2* -2.4* -0.4

Mean change in

PPG from baseline,

mmol/L -2.6 -2.7* -0.8

% reporting minor

hypoglycemic 9 8 5

events/subject/year 0.38 0.64* 0.17

Mean change in

systolic blood

pressure from

baseline, mmHg -6.7* -5.6* -1.1

*p<0.05 versus placebo

FPG, fasting plasma glucose; OAD, oral antidiabetic drug; PPG,

post-prandial glucose

Safety and tolerability of liraglutide

There were no major hypoglycemic episodes reported during the study. The rate of minor hypoglycemia (<3.1 mmol/L) was low in all groups (0.38, 0.64 and 0.17 events per subject year with liraglutide 1.2 mg, 1.8 mg and placebo, respectively). The most frequent adverse event was nausea, which was reported by 29-40% of patients treated with 1.2 mg and 1.8 mg respectively. However, nausea levels decreased to the same as the placebo group after the first 16 week

SOURCE Novo Nordisk
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015  The National Heart, ... $40 million to the Broad Institute of MIT ... of 20,000 individuals, as well as data to ... profiling. Trans-Omics for Precision Medicine ... toward a larger initiative, which will use whole ...
(Date:10/8/2015)...  Nektar Therapeutics (Nasdaq: NKTR ) will present ... during an Investor and Analyst R&D Day being hosted ... New York City . ... 1/2 clinical program and biomarker strategy will be presented.  ... stimulate the production of CD8-positive T-cells.  The Company will ...
(Date:10/8/2015)... -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company, ... the Centers for Medicare & Medicaid Services (CMS) to drastically ... gene expression levels to help clinicians determine a heart transplant ... of this story on CNBC . [ Link ... on CNBC . [ Link ] --> ...
Breaking Medicine Technology:
... , BERKELEY HEIGHTS, N.J. , June 15 Access ... president and chief executive officer (CEO). Since mid-2009, Access was under the ... served in addition to his responsibilities as chief financial officer (CFO). ... "I am humbled and ...
... June 15 Eleme Medical Inc., a ... all areas of body shaping, announced today that CEO ... recipient of a Leadership Award from non-profit group Women ... scientists and engineers to develop an entrepreneurial mindset and ...
Cached Medicine Technology:
(Date:10/9/2015)... ... October 09, 2015 , ... Matrix IT Medical ... specifications for TRACTUS, the world’s first sterile field scanner. , The ... to the FDA’s recent Unique Device Identifier (UDI) Final Rule, which will require ...
(Date:10/9/2015)... PA (PRWEB) , ... October 09, 2015 , ... "As ... of two inventors from Philadelphia, Pa. "They have to wear large diapers or pads. ... solutions." , They developed the TROUSAFE to absorb urine leaking from the tip of ...
(Date:10/9/2015)... ... October 09, 2015 , ... Ryan Fox, the ... recreational dispensaries in Colorado, says the latest figures on the state’s sales of ... into a legitimate industry. , Last month, according to the website ...
(Date:10/9/2015)... Carolina (PRWEB) , ... October 09, 2015 , ... ... care and medical staffing franchise, was recognized by Cabarrus County Active Living and ... the local home care company’s dedication to consistently going above and ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... in Franklin County, North Carolina and nearby communities, launched a new website to ... allows victims of domestic violence to find help immediately, whether through an emergency ...
Breaking Medicine News(10 mins):
... Coastal Health Research Institute study has found that a ... of developing bone necrosis, a condition that can lead ... the largest study of bone necrosis and bisphosphonates, a ... to help prevent bone fractures due to osteoporosis. It ...
... protect against spread of disease , TUESDAY, Jan. 15 ... with HIV might also prevent vaginal transmission of the ... of Texas Southwestern Medical Center at Dallas. , The ... about 6,800 new transmissions daily, occur through unprotected vaginal ...
... for imported food increases, the urgency for quality controls does ... (HealthDay News) -- One Sunday after church, Rich Miller headed ... he dipped into the house salsa that came with the ... life forever. What Miller didn,t know was that imported Mexican ...
... pulmonary fibrosis (IPF), an untreatable progressive lung disease that ... diagnosis, have a worse prognosis than non-smokers, according to ... that current smokers with IPF might live longer than ... likely reflected a healthy smoker effect. , The study ...
... with an education platform to start a dialogue,with ... Papillomavirus (HPV),cervical cancer preventative vaccines., VAN NUYS, ... (NCCC) announces the formation of four new,chapters nationwide ... communities about the cervical cancer HPV preventative vaccines. ...
... LOS ANGELES, Jan. 15 It,s time to think about ... star on the high school golf,circuit in southern California., ... competing in tournaments, I am,constantly doing a variety of things ... Here are some ideas to get ...
Cached Medicine News:
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: